Patents Assigned to Inimmune Corp.
  • Monoclonal antibody and vaccine targeting filamentous bacteriophage
    Patent number: 12661411
    Abstract: Described here is a method for reducing or preventing Pseudomonas aeruginosa biofilm formation in a human subject in need thereof, comprising administering to the human subject a first composition comprising (a) an antigen-binding polypeptide that binds Pf-family bacteriophage, or (b) a vaccine against Pf-family bacteriophage. Also described is an antigen-binding polypeptide that binds specifically to a CoaB protein of Pf-family bacteriophage or fragment thereof.
    Type: Grant
    Filed: January 29, 2024
    Date of Patent: June 23, 2026
    Assignee: Inimmune Corp.
    Inventors: Paul L. Bollyky, William Parks, Patrick Secor